Horizon Therapeutics Chairman, President and CEO Tim Walbert Named the First Recipient of the Global Rare Trailblazer Award by The Sumaira Foundation

BOSTON, June 14, 2023 /PRNewswire/ — The Sumaira Foundation (TSF), a global patient advocacy organization focused on rare neuroimmune conditions, is delighted to announce Tim Walbert, chairman, president and chief executive officer of Horizon Therapeutics, as TSF’s Inaugural Global Rare Trailblazer Award recipient. The award was announced at the 6th Annual TSF Gala, recently held in … Read more